Skip to main content
Impact Reports

Impact Report

Quarterly reports on how philanthropic support is fueling innovation at MSK, making an impact on the lives of cancer patients around the world.


Fall 2018

A 21st Century Bone Marrow Transplant

A 21st Century Bone Marrow Transplant

Beginning in the 1970s, bone marrow transplants (BMTs) have offered a chance of cure for many people with leukemias, lymphomas, and other blood disorders. An allogeneic BMT replaces a patient’s suppressed immune system with a new, healthy one — grown from donor stem cells or bone marrow. While BMTs are successful in 60 to 70 percent of patients, the procedure carries significant risk — including graft-versus-host disease (GVHD), which can occur when the newly transplanted cells attack the “foreign” host tissue. 

Jay O'Brien

Meet Jay O'Brien

I was a college athlete and coach, and I’ve always been in good shape. I also worked in the athletic footwear business for a long time.

In 2008, my wife and I were on one of our long walks, and I couldn’t make it up a hill. My heart was pounding like crazy — but I wasn’t sweating. I saw my primary care doctor in New Jersey.

The moment he saw me he was so concerned that he ordered blood work immediately. That afternoon, his office called — go to the ER. And that’s where my wife and I learned I had leukemia.

Marcel van den Brink

A Visit with Marcel van den Brink

Meet Marcel van den Brink, MD, PhD, whose research includes optimizing gut microbiota — the bacteria, or flora, that live in the gut — to improve outcomes following BMT. He also develops cell therapies to strengthen the immune system after transplant. While primarily focused on BMT, Dr. van den Brink’s work holds potential against many diseases.

Summer 2018

Outsmarting Lung Cancer

Outsmarting Lung Cancer

Lung cancer is one of the most difficult cancers to detect, and therefore to treat. But MSK physicians and scientists are introducing new approaches, called immunotherapies, which can help some lung cancer patients defeat the disease. Because of thoughtful donors like you, people are living beyond cancer.

Steve Cara

Reversing Cancer: Steve's Story

Apparel industry executive Steve Cara was 52 years old when he learned from his insurance agent that he had cancer. He had just taken a blood test to increase his life policy’s value. The diagnosis: lung cancer.

Matthew Hellmann, MD

A Visit with Matthew Hellmann

Lung cancer is still the leading cause of all deaths from cancer in the country and worldwide. Many patients with lung cancers have never smoked. Fortunately, new medicines such as immunotherapies are beginning to provide hope for patients with these diseases.